Aldehyde dehydrogenase 2 attenuates renal injury through inhibiting CYP4A expression
Translational Research · 2025
DOI: 10.1016/j.trsl.2024.12.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2025. Verfasst von Hao Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Labo…. Hauptthemen laut MEDLINE: Aldehyde Dehydrogenase, Mitochondrial, Cytochrome P-450 CYP4A, Reperfusion Injury, Kidney. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Renal ischemia-reperfusion injury (IRI) is a prevalent clinical syndrome, yet its underlying pathogenesis remains largely unknown. Aldehyde dehydrogenase 2 (ALDH2), an enzyme responsible for detoxifying lipid aldehydes, has been suggested to play a protective role against IRI. In our study, we observed that Aldh2 knock-out C57BL/6 mice experienced more severe renal functional impairment following IRI. This was characterized by elevated levels of creatinine and blood urea nitrogen, as well as increased apoptosis. Proteomic analysis further revealed that ALDH2 deficiency significantly disrupted lipid metabolism, resulting in higher levels of the proinflammatory protein CYP4A and its metabolic byproduct, 20-HETE. This metabolic disruption exacerbated renal inflammation and triggered endoplasmic reticulum stress. However, we found that administration of the CYP4A inhibitor, HET0016, could ameliorate these effects. Mechanistically, we discovered that after IRI, ALDH2 translocates to the nucleus and interacts with nuclear receptor corepressor 1 (NCOR1) to repress Cyp4a transcription. ALDH2 specifically interacts with the N-terminal domain of NCOR1, which is responsible for its interaction with its E3 ligase SIAH2. This interaction inhibits the proteasome degradation of NCOR1, ultimately stabilizing the NCOR1 transcriptional repression complex. In summary, our research uncovers the role of ALDH2 in mitigating renal IRI by inhibiting 20-HETE synthesis through the transcriptional repression of Cyp4a.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Engineering Research…
- Department of Liver Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, 160 Pujian Road, Pudong New Area,Shanghai 200127, China.
Zitieren
APA
Chen, H., Hu, Q., Lu, Z., Zhao, J., Liu, A., Liu, Z., Luo, J., Ye, Q., & Zhong, Z. (2025). Aldehyde dehydrogenase 2 attenuates renal injury through inhibiting CYP4A expression. Translational Research. https://doi.org/10.1016/j.trsl.2024.12.007
Vancouver
Chen H, Hu Q, Lu Z, Zhao J, Liu A, Liu Z, et al. Aldehyde dehydrogenase 2 attenuates renal injury through inhibiting CYP4A expression. Translational Research. 2025. doi:10.1016/j.trsl.2024.12.007
BibTeX
@article{Chen2025,
author = {Chen, Hao and Hu, Qianchao and Lu, Zhongshan and Zhao, Jie and Liu, Anxiong and Liu, Zhongzhong and Luo, Jun and Ye, Qifa and Zhong, Zibiao},
title = {Aldehyde dehydrogenase 2 attenuates renal injury through inhibiting CYP4A expression},
journal = {Translational Research},
year = {2025},
doi = {10.1016/j.trsl.2024.12.007}
}
EUVIMED